Karyopharm - oncology

















Down to $1.14
Only fools stay here or continue to throw good money after bad. If there was any value here big pharma would come in and pick this up. Only conclusion is that this company is too toxic and no to minimal upside.

DDD continues to pump this stock. If he really thought this was a great big buy why isn’t he buying 100,000 lots at the going out of business stock price on a daily basis to get in before a buyout? Because in reality this is a busted stock and a busted company. The market cap is so low indicating bankruptcy in the near future.

The science may be sound but the company has trashed the fiscal component and the reputation of the business.

Only fools rush in where angels fear to tread.

Wake up people! You have been warned.